7.15
Precedente Chiudi:
$6.65
Aprire:
$6.67
Volume 24 ore:
177.30K
Relative Volume:
0.79
Capitalizzazione di mercato:
$259.50M
Reddito:
$16.10M
Utile/perdita netta:
$-42.57M
Rapporto P/E:
-5.0698
EPS:
-1.4103
Flusso di cassa netto:
$-38.53M
1 W Prestazione:
+14.04%
1M Prestazione:
+41.30%
6M Prestazione:
+23.70%
1 anno Prestazione:
+49.58%
Profound Medical Corp Stock (PROF) Company Profile
Nome
Profound Medical Corp
Settore
Industria
Telefono
647-476-1350
Indirizzo
2400 SKYMARK AVENUE, UNIT 6, MISSISSAUGA, ON
Compare PROF vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
PROF
Profound Medical Corp
|
7.15 | 241.35M | 16.10M | -42.57M | -38.53M | -1.4103 |
|
ABT
Abbott Laboratories
|
96.00 | 168.22B | 45.13B | 6.28B | 7.40B | 3.5895 |
|
SYK
Stryker Corp
|
338.34 | 131.49B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
85.00 | 110.66B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
60.99 | 95.46B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
81.44 | 46.69B | 6.07B | 1.06B | 1.34B | 1.8063 |
Profound Medical Corp Stock (PROF) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-07-23 | Iniziato | Lake Street | Buy |
| 2024-07-16 | Aggiornamento | Stifel | Hold → Buy |
| 2023-11-28 | Iniziato | Stifel | Hold |
| 2023-08-04 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2023-03-21 | Downgrade | Jefferies | Buy → Hold |
| 2020-09-15 | Iniziato | Jefferies | Buy |
Mostra tutto
Profound Medical Corp Borsa (PROF) Ultime notizie
Profound Medical : Investor Presentation (Profound Investor Presentation April 2026 ver9final) - marketscreener.com
Profound Medical : Investor Presentation (Profound Investor Presentation April 2026 ver8final) - marketscreener.com
Profound Medical to Release First Quarter 2026 Financial Results on May 7Conference Call to Follow - Investing News Network
Profound Medical : FY 2025 Management Information Circular - marketscreener.com
Profound Medical Schedules First-Quarter 2026 Earnings Release - TipRanks
Profound Medical (NASDAQ: PROF) to report Q1 2026 results, host call May 7 - Stock Titan
Profound Medical to Release First Quarter 2026 Financial Results on May 7 – Conference Call to Follow - The Spec
PROF SEC FilingsProfound Med Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Profound Medical Corp. - Mena FN
Stocks in play: Profound Medical Corp. - The Globe and Mail
Profound Medical to Present Business Update at Conference - TipRanks
Profound Medical to Participate in the 2026 Bloom Burton & Co. Healthcare Investor Conference - The Manila Times
Profound Medical (NASDAQ: PROF) plans business update at 2026 Bloom Burton healthcare investor conference - Stock Titan
Income Plays: Is Profound Medical Corp trading at a discountRisk Management & Long-Term Growth Portfolio Plans - baoquankhu1.vn
Aug Analyst Calls: Is Profound Medical Corp showing insider buying2026 Technicals & Expert-Curated Trade Recommendations - baoquankhu1.vn
Buy Signal: Is Profound Medical Corp in a bullish channel2026 Momentum & Low Risk Growth Stock Ideas - baoquankhu1.vn
Profound Medical (PROF) price target decreased by 26.77% to 8.49 - MSN
Understanding the Setup: (PROF) and Scalable Risk - Stock Traders Daily
If You Invested $1,000 in Profound Med Corp (PROF) - Stock Titan
Rate Cut: What hedge funds are buying Profound Medical Corp2026 Gainers & AI Driven Price Predictions - baoquankhu1.vn
Profound Medical Corp. Investigated by the Portnoy Law Firm - GlobeNewswire
Short Squeeze: Can Profound Medical Corp sustain its profitability2026 Top Gainers & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
Forecast Cut: Is Profound Medical Corp being accumulated by smart moneyGlobal Markets & AI Powered Market Entry Strategies - baoquankhu1.vn
Insider Buying: Profound Medical (TSE:PRN) Director Acquires 20,000 Shares of Stock - MarketBeat
Profound Medical Showcases TULSA-PRO at Key Radiology Meeting - TipRanks
Incision-Free, MRI-Guided Prostate Treatment with Profound's TULSA-PRO to be Featured in Multiple Presentations at the Upcoming 2026 Society of Interventional Radiology Scientific Meeting - Bitget
Profound Medical’s TULSA-PRO® Incision-Free, MRI-Guided Prostate Treatment Highlighted at 2026 Society of Interventional Radiology Meeting - Minichart
Incision-Free, MRI-Guided Prostate Treatment with Profound's TULSA-PRO® to be Featured in Multiple Presentations at the Upcoming 2026 Society of Interventional Radiology Scientific Meeting - Investing News Network
Incision-Free, MRI-Guided Prostate Treatment with Profound’s TULSA-PRO® to be Featured in Multiple Presentations at the Upcoming 2026 Society of Interventional Radiology Scientific Meeting - The Manila Times
Profound Medical: TULSA-PRO highlighted in multiple presentations at SIR 2026 - TradingView
TULSA-PRO showcased at SIR 2026 for Profound Medical (NASDAQ: PROF) - Stock Titan
Incision-free prostate treatment lands 7 talks at April medical meeting - Stock Titan
PROF Technical Analysis & Stock Price Forecast - Intellectia AI
Short Interest in Profound Medical (NASDAQ:PROF) Expands By 19.8% - marketbeat.com
Profound Medical Congratulates Texas Prostate on Achieving 100th TULSA Procedure Milestone - MarketScreener
Profound Medical (NASDAQ:PROF) Trading Down 1.7%Time to Sell? - marketbeat.com
Profound Medical (TSE:PRN) Stock Price Down 2.6%Time to Sell? - MarketBeat
Income Plays: Is Profound Medical Corp showing insider buyingStop Loss & AI Based Buy/Sell Signal Reports - baoquankhu1.vn
Profound Medical Touts Positive Trial Results for MRI-Guided TULSA Procedure - Medical Product Outsourcing
Profound Medical Marks Key TULSA Milestone as Texas Prostate Tops 100 Procedures - tipranks.com
Profound Medical Congratulates Texas Prostate on Achieving 100th TULSA Procedure™ Milestone - The Manila Times
Dallas prostate center says Medicare shift lifted TULSA cases 500% - Stock Titan
Profound Medical (PROF) Surges 13.0%: Is This an Indication of Further Gains? - finance.yahoo.com
Q2 2025 Profound Medical Corp Earnings Call Transcript - gurufocus.com
Trading Action: How does Profound Medical Corp perform in inflationary periodsWeekly Trade Recap & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Dip Buying: Is Profound Medical Corp showing insider buying2026 Review & Daily Stock Momentum Reports - baoquankhu1.vn
Precision Trading with Profound Medical Corp. (PROF) Risk Zones - Stock Traders Daily
Top 3 Health Care Stocks That Are Set To Fly In March - Benzinga
Profound Medical stock rating reiterated by Raymond James on trial data - Investing.com India
Returns Recap: Can Profound Medical Corp sustain its profitability2026 Macro Moves & Fast Momentum Stock Entry Tips - baoquankhu1.vn
Profound Medical Corp Azioni (PROF) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):